MEIP Insider Trading Activity and SEC Form 4 Filings
MEIP insider trading summary
No open-market insider purchases or sales of MEI Pharma, Inc. (MEIP) have been reported on SEC Form 4 in the past 12 months.
Latest MEIP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 22, 2023 | Moez Kassam | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Anson Management GP LLC | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Jacob Ma-Weaver | 10% Owner | Buy | $220K (32,040 @ $6.85) |
| Sep 22, 2023 | Amin Nathoo | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Cable Car Capital LLC | 10% Owner | Buy | $220K (32,040 @ $6.85) |
| Sep 22, 2023 | Bruce Ross Winson | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Anson Funds Management LP | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Anson Advisors Inc. | 10% Owner | Buy | $329K (48,060 @ $6.85) |
| Sep 22, 2023 | Funicular Funds, LP | 10% Owner | Buy | $220K (32,040 @ $6.85) |
| Sep 21, 2023 | Anson Management GP LLC | 10% Owner | Buy | $217K (33,600 @ $6.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.